Previous close | 352.40 |
Open | 355.80 |
Bid | 348.40 x 0 |
Ask | 363.10 x 0 |
Day's range | 353.00 - 357.60 |
52-week range | 274.90 - 432.50 |
Volume | |
Avg. volume | 1,234,774 |
Market cap | 98.405B |
Beta (5Y monthly) | 0.44 |
PE ratio (TTM) | 28.86 |
EPS (TTM) | 12.32 |
Earnings date | N/A |
Forward dividend & yield | 10.20 (3.59%) |
Ex-dividend date | 11 Oct 2023 |
1y target est | 411.63 |
AXTA vs. NVZMY: Which Stock Is the Better Value Option?
EU antitrust regulators have extended their date for a decision on the tie-up of Danish food ingredients and enzymes makers Novozymes and Chr. Hansen to Dec. 12 after the companies offered remedies to address competition concerns. Novozyme, which makes enzymes for household products, food and beverages and biofuels, and Chr.
Novozymes, a global leader in biosolutions, marks a significant milestone in the renewable diesel and SAF (Sustainable Aviation Fuel) industry with the launch of Quara® LowP, an enzymatic solution designed to transform the feedstock pre-treatment process. Copenhagen, Denmark – 9 November, 2023. As the world seeks sustainable alternatives to traditional fuels, renewable diesel and SAF production have taken center stage. By 2030, vegetable oils are projected to account for over 40% of global feeds